• E-Steroid.com
  • E-Steroid.com
  • E-Steroid.com
  • E-Steroid.com
  • E-Steroid.com
  • E-Steroid.com
  • E-Steroid.com
  • E-Steroid.com

Steroids Cycles “Beginner, Intermediate and Advanced Steroids Cycles...”

anabolic steroids
e-steroid.com
anabolic steroids

Steroids Information Online “Steroids cannot be ignored in any sport, they are reality...”

 
 
 
UnderGround Steroids Secrets

Ultimate 10 Part Steroid Cycle Guide

Steroid Cycle Guide Ultimate 10 part

only available for
the next

First Name:
Email Address:

 

Acute Psoriasis Patients get benefited by short-term topical corticosteroids
Share on Tumblr
Follow Me on Pinterest

November 6, 2009  |  Posted in  Steroids Blog

Acute Psoriasis Patients get benefited by short-term topical corticosteroidsAccording to a recently concluded study by Alexander Kreuter, M.D, from Ruhr University of Bochum, Germany and colleagues, short-term application of topical corticosteroids and maintenance with a less potent agent can prove helpful to patients with IP (intertriginous psoriasis).

From Bio-Medicine.Org:

In this study, Alexander Kreuter, M.D, from Ruhr University of Bochum, Germany, and colleagues conducted a randomized controlled trial that compared 1 percent pimecrolimus (a new anti-inflammatory drug), 0.005 percent calcipotriol, 0.1 percent betamethasone and the vehicle (a similarly appearing cream with no active drug) in the treatment of IP with a four-week treatment period and a six-week follow-up without therapy. A total of 80 adult patients with the clinical diagnosis of IP were included, 20 patients in each of the four treatment groups.

“After four weeks of treatment, the three active compounds and the vehicle resulted in a significant decrease in mean (average) M-PASI score [Modified Psoriasis Area and Severity Index] (86.4 percent for 0.1 percent betamethasone, 62.4 percent for 0.005 percent calcipotriol, 39.7 percent for 1 percent pimecrolimus and 21.1 percent for vehicle),” the researchers found. “The 0.1 percent betamethasone was significantly more effective than 1 percent pimecrolimus during the study period.”

The findings of this study are expected to offer great relief to IP patients worldwide, who have been complaining of soreness and irritation from sweating. The previously-believed myth that corticosteroids bring some side effects with them when used in the long term was also refuted during this study.

In short, the study remarked that a short-term application of corticosteroids for acute disease followed by maintenance treatment with any of the less potent agents is regarded as a reasonable approach for the treatment of intertriginous psoriasis (IP).


RSS Email Subscription


 

buy steroids